These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 12818205

  • 21. Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma.
    Kipriyanov SM, Cochlovius B, Schäfer HJ, Moldenhauer G, Bähre A, Le Gall F, Knackmuss S, Little M.
    J Immunol; 2002 Jul 01; 169(1):137-44. PubMed ID: 12077238
    [Abstract] [Full Text] [Related]

  • 22. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A, Plückthun A.
    Biochemistry; 1998 Sep 22; 37(38):13120-7. PubMed ID: 9748318
    [Abstract] [Full Text] [Related]

  • 23. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
    Kim SH, Schindler DG, Lindner AB, Tawfik DS, Eshhar Z.
    Mol Immunol; 1997 Sep 22; 34(12-13):891-906. PubMed ID: 9464525
    [Abstract] [Full Text] [Related]

  • 24. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
    Ayala M, Balint RF, Fernández-de-Cossío L, Canaán-Haden JW, Larrick JW, Gavilondo JV.
    Biotechniques; 1995 May 22; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
    [Abstract] [Full Text] [Related]

  • 25. CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis.
    Mølhøj M, Crommer S, Brischwein K, Rau D, Sriskandarajah M, Hoffmann P, Kufer P, Hofmeister R, Baeuerle PA.
    Mol Immunol; 2007 Mar 22; 44(8):1935-43. PubMed ID: 17083975
    [Abstract] [Full Text] [Related]

  • 26. Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module.
    Stamova S, Cartellieri M, Feldmann A, Arndt C, Koristka S, Bartsch H, Bippes CC, Wehner R, Schmitz M, von Bonin M, Bornhäuser M, Ehninger G, Bachmann M.
    Mol Immunol; 2011 Dec 22; 49(3):474-82. PubMed ID: 22014687
    [Abstract] [Full Text] [Related]

  • 27. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S, Bosman F, Buyse MA, Degrieck R, Celis L, de Boer M, Van Doorsselaere V, Sablon E.
    Protein Expr Purif; 2001 Jun 22; 22(1):11-24. PubMed ID: 11388794
    [Abstract] [Full Text] [Related]

  • 28. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
    Albrecht H, Denardo GL, Denardo SJ.
    J Immunol Methods; 2006 Mar 20; 310(1-2):100-16. PubMed ID: 16499921
    [Abstract] [Full Text] [Related]

  • 29. Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas.
    Helfrich W, Kroesen BJ, Roovers RC, Westers L, Molema G, Hoogenboom HR, de Leij L.
    Int J Cancer; 1998 Apr 13; 76(2):232-9. PubMed ID: 9537586
    [Abstract] [Full Text] [Related]

  • 30. A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens.
    Moore GL, Bautista C, Pong E, Nguyen DH, Jacinto J, Eivazi A, Muchhal US, Karki S, Chu SY, Lazar GA.
    MAbs; 2011 Apr 13; 3(6):546-57. PubMed ID: 22123055
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of human B cell lymphoma xenografts with a CD3 x CD19 diabody and T cells.
    Cochlovius B, Kipriyanov SM, Stassar MJ, Christ O, Schuhmacher J, Strauss G, Moldenhauer G, Little M.
    J Immunol; 2000 Jul 15; 165(2):888-95. PubMed ID: 10878363
    [Abstract] [Full Text] [Related]

  • 33. A dimeric bispecific miniantibody combines two specificities with avidity.
    Müller KM, Arndt KM, Plückthun A.
    FEBS Lett; 1998 Jul 31; 432(1-2):45-9. PubMed ID: 9710248
    [Abstract] [Full Text] [Related]

  • 34. Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.
    Fortmüller K, Alt K, Gierschner D, Wolf P, Baum V, Freudenberg N, Wetterauer U, Elsässer-Beile U, Bühler P.
    Prostate; 2011 May 31; 71(6):588-96. PubMed ID: 20945402
    [Abstract] [Full Text] [Related]

  • 35. [New type recombinant antibody fragment scFv multimer and cancer targeting].
    Guo J, Cai M.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun 31; 20(2):361-5. PubMed ID: 12856620
    [Abstract] [Full Text] [Related]

  • 36. Antigen mimicry by an anti-idiotypic antibody single chain variable fragment.
    Tripathi PK, Qin H, Deng S, Xu C, Bhattacharya-Chatterjee M, Foon KA, Chatterjee SK.
    Mol Immunol; 1998 Sep 31; 35(13):853-63. PubMed ID: 9839554
    [Abstract] [Full Text] [Related]

  • 37. Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapy.
    DeNardo DG, Xiong CY, Shi XB, DeNardo GL, DeNardo SJ.
    Cancer Biother Radiopharm; 2001 Dec 31; 16(6):525-35. PubMed ID: 11789029
    [Abstract] [Full Text] [Related]

  • 38. Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers.
    Arndt MA, Krauss J, Rybak SM.
    FEBS Lett; 2004 Dec 17; 578(3):257-61. PubMed ID: 15589829
    [Abstract] [Full Text] [Related]

  • 39. Construction of a diabody (small recombinant bispecific antibody) using a refolding system.
    Takemura S, Asano R, Tsumoto K, Ebara S, Sakurai N, Katayose Y, Kodama H, Yoshida H, Suzuki M, Imai K, Matsuno S, Kudo T, Kumagai I.
    Protein Eng; 2000 Aug 17; 13(8):583-8. PubMed ID: 10964988
    [Abstract] [Full Text] [Related]

  • 40. IgM secretory tailpiece drives multimerisation of bivalent scFv fragments in eukaryotic cells.
    Olafsen T, Rasmussen IB, Norderhaug L, Bruland OS, Sandlie I.
    Immunotechnology; 1998 Oct 17; 4(2):141-53. PubMed ID: 9853955
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.